Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 36 páginas
Examen

New Jersey Drug Safety and Pharmacovigilance Certification Exam Questions and Correct Answers | Adverse Event Reporting, Signal Detection, Risk Management & Drug Safety Compliance Guide

Document preview thumbnail
Vista previa 4 fuera de 36 páginas

Prepare for the New Jersey Drug Safety and Pharmacovigilance Certification Exam with this comprehensive collection of exam-style questions and correct answers. This study guide covers pharmacovigilance principles, adverse event reporting, Individual Case Safety Reports (ICSRs), signal detection, risk management plans, benefit-risk assessment, post-marketing surveillance, MedDRA coding, pharmacoepidemiology, FDA and EMA regulations, ICH guidelines, aggregate safety reporting, safety data analysis, pharmacovigilance audits, CAPA, safety management systems, and global drug safety compliance. It is designed for drug safety associates, pharmacovigilance specialists, regulatory affairs professionals, clinical research personnel, quality professionals, and pharmaceutical industry candidates seeking certification success and career advancement. Drug safety and pharmacovigilance programs commonly emphasize adverse event management, signal detection, risk mitigation, regulatory reporting, and patient safety throughout the product lifecycle.

Vista previa del contenido

New Jersey Drug Safety And
Pharmacovigilance Certification Exam
Question and correct
answers (verified answers 100%) Q&A
2026/2027 INSTANT DOWNLOAD PDF


1. What is the primary purpose of pharmacovigilance?
A. To increase drug sales
B. To detect, assess, understand, and prevent adverse drug reactions
C. To develop marketing campaigns
D. To reduce manufacturing costs
Correct Answer: B
Rationale: Pharmacovigilance focuses on detecting, assessing, understanding, and
preventing adverse effects or other drug-related problems to improve patient
safety.


2. Which term refers to an unwanted and harmful reaction occurring at normal
drug doses?
A. Therapeutic effect
B. Adverse Drug Reaction (ADR)
C. Indication
D. Contraindication

,Correct Answer: B
Rationale: An ADR is a harmful and unintended response to a medicinal product
used at normal doses.


3. Which federal program allows healthcare professionals and consumers to
report adverse drug events?
A. Medicare
B. Medicaid
C. FDA MedWatch
D. DEA Watch
Correct Answer: C
Rationale: FDA MedWatch is the national reporting system for adverse events and
product safety concerns.


4. What does ICSR stand for in pharmacovigilance?
A. International Clinical Safety Report
B. Individual Case Safety Report
C. Integrated Case Study Record
D. Internal Clinical Surveillance Review
Correct Answer: B
Rationale: An ICSR is the standard format used to document and report adverse
event cases.


5. Which phase of a drug's lifecycle relies heavily on post-marketing
surveillance?
A. Discovery
B. Preclinical Research

,C. Phase I Trials
D. Post-Approval Marketing
Correct Answer: D
Rationale: Post-marketing surveillance monitors drug safety after approval when
larger populations use the product.


6. What is the primary goal of signal detection?
A. Increase prescriptions
B. Identify potential new safety concerns
C. Improve packaging
D. Reduce clinical trials
Correct Answer: B
Rationale: Signal detection identifies patterns suggesting possible new risks
associated with a drug.


7. Which organization defines pharmacovigilance globally?
A. CDC
B. WHO
C. DEA
D. NIH
Correct Answer: B
Rationale: The World Health Organization provides internationally accepted
definitions and guidance for pharmacovigilance.


8. Which of the following is considered a serious adverse event (SAE)?

, A. Mild headache
B. Temporary nausea
C. Hospitalization
D. Dry mouth
Correct Answer: C
Rationale: Events causing hospitalization, death, disability, or life-threatening
conditions are classified as serious.


9. What is the purpose of risk management plans (RMPs)?
A. Increase revenue
B. Minimize and monitor drug risks
C. Eliminate competitors
D. Reduce labeling requirements
Correct Answer: B
Rationale: RMPs identify, evaluate, and minimize risks associated with medicinal
products.


10. Which source is commonly used for spontaneous adverse event reporting?
A. Healthcare professionals
B. Marketing agencies
C. Insurance brokers
D. Product suppliers
Correct Answer: A
Rationale: Healthcare professionals are major contributors to spontaneous safety
reporting systems.


11. What does causality assessment determine?

Información del documento

Subido en
15 de agosto de 2026
Número de páginas
36
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$23.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
2
Seguidores
0
Artículos
924
Última venta
4 días hace


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes